Holen Sie sich die Stockscreener-App
28.01
7.77%
2.02
Handel nachbörslich:
28.57
0.56
+2.00%
Schlusskurs vom Vortag:
$25.99
Offen:
$26.08
24-Stunden-Volumen:
314.43K
Relative Volume:
1.21
Marktkapitalisierung:
$865.86M
Einnahmen:
$290.71M
Nettoeinkommen (Verlust:
$-163.43M
KGV:
-5.1113
EPS:
-5.48
Netto-Cashflow:
$11.70M
1W Leistung:
+6.62%
1M Leistung:
+0.79%
6M Leistung:
+45.20%
1J Leistung:
+47.81%
1-Tages-Spanne:
$26.07
$28.04
1-Wochen-Bereich:
$25.07
$28.04
52-Wochen-Spanne:
$14.76
$31.04
Fulgent Genetics Inc Stock (FLGT) Company Profile
Firmenname
Fulgent Genetics Inc
Sektor
Branche
Telefon
626-350-0537
Adresse
4399 SANTA ANITA AVE, EL MONTE
Vergleichen Sie FLGT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FLGT
Fulgent Genetics Inc
|
28.01 | 803.41M | 290.71M | -163.43M | 11.70M | -5.48 |
|
TMO
Thermo Fisher Scientific Inc
|
617.15 | 233.21B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.57 | 167.12B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
714.55 | 56.44B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
147.81 | 41.84B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
244.29 | 40.96B | 15.90B | 1.28B | 2.21B | 7.2842 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-05 | Hochstufung | UBS | Neutral → Buy |
| 2023-12-07 | Eingeleitet | UBS | Neutral |
| 2022-12-08 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-11-18 | Eingeleitet | Raymond James | Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-02-04 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Underperform |
| 2021-01-08 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2020-11-24 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-08-20 | Eingeleitet | Oppenheimer | Outperform |
| 2020-05-29 | Eingeleitet | BTIG Research | Buy |
| 2019-11-05 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-03-01 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
Alle ansehen
Fulgent Genetics Inc Aktie (FLGT) Neueste Nachrichten
Fulgent Genetics (NASDAQ:FLGT) Stock Price Up 7.3%Time to Buy? - MarketBeat
How Fulgent Genetics Inc. stock performs in stagflation2026 world cup usa national team quarterfinals defensive leaders high defensive line match prediction breakdown - Улправда
Fulgent Genetics (NASDAQ:FLGT) vs. Mitesco (OTCMKTS:MITI) Critical Analysis - Defense World
Liquidity Mapping Around (FLGT) Price Events - Stock Traders Daily
FLGT to acquire Bako & StrataDx assets to expand pathology platform - MSN
Squarepoint Ops LLC Cuts Position in Fulgent Genetics, Inc. $FLGT - MarketBeat
FLGT to Acquire Bako & StrataDx Assets to Expand Pathology Platform - Finviz
Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx - BioSpace
Fulgent Genetics to acquire StrataDx and selected assets of Bako Diagnostics - Medical Buyer
Fulgent Genetics to buy Bako Diagnostics assets and StrataDx - Yahoo Finance
Fulgent Genetics to acquire select assets of Bako Diagnostics and StrataDx for $55.5m - pehub.com
Latham & Watkins Advises on Fulgent Genetics’ Acquisition of Bako Diagnostics and StrataDX - Legal Desire Media and Insights
Fulgent Genetics to Acquire Bako Diagnostics and StrataDx - citybiz
Fulgent Genetics to acquire Bako Diagnostics and StrataDx for $55.5 million - Investing.com Nigeria
Fulgent Genetics to acquire Bako Diagnostics and StrataDx for $55.5 million By Investing.com - Investing.com South Africa
Fulgent Genetics (FLGT) to Acquire Assets from Bako Diagnostics and StrataDx - GuruFocus
Fulgent Genetics to Acquire Bako Diagnostics and StrataDx for $55.5 Million - MarketScreener
How Fulgent Genetics Inc. stock performs during Fed tightening cyclesJuly 2025 Macro Moves & Precise Swing Trade Alerts - Улправда
Why Fulgent Genetics Inc. (7F0) stock attracts wealthy investorsForecast Cut & Advanced Technical Signal Analysis - Улправда
Understanding the Setup: (FLGT) and Scalable Risk - Stock Traders Daily
How Fulgent Genetics Inc. stock performs in rate cut cyclesJuly 2025 Levels & Free Safe Entry Trade Signal Reports - ulpravda.ru
Will Fulgent Genetics Inc. stock outperform tech sector in 2025Analyst Downgrade & Real-Time Price Movement Reports - Улправда
Will Fulgent Genetics Inc. stock outperform value stocksMarket Trend Review & Verified Short-Term Plans - Улправда
Will Fulgent Genetics Inc. stock continue dividend increasesWeekly Earnings Recap & Intraday High Probability Setup Alerts - Улправда
Is Fulgent Genetics Inc. stock a buy before product launchesPortfolio Update Report & Entry Point Confirmation Signals - DonanımHaber
Published on: 2025-12-19 03:22:26 - Улправда
Why Fulgent Genetics Inc. stock remains on buy listsJuly 2025 Chart Watch & Accurate Intraday Trade Tips - Улправда
Fulgent Genetics (NASDAQ:FLGT) Rating Lowered to "Hold" at Wall Street Zen - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Rating Lowered to “Hold” at Wall Street Zen - Defense World
The Technical Signals Behind (FLGT) That Institutions Follow - Stock Traders Daily
Fulgent Genetics Shares Surge on Unexpected Profit and Raised Outlook - AD HOC NEWS
Diametric Capital LP Makes New $3.36 Million Investment in Fulgent Genetics, Inc. $FLGT - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Insider Sells $30,454.75 in Stock - MarketBeat
How Fulgent Genetics Inc. (7F0) stock performs during market turbulenceTrade Volume Report & Low Risk Growth Stock Ideas - Newser
Can Fulgent Genetics Inc. (7F0) stock resist broad market declinesWeekly Trend Report & Safe Entry Point Identification - Newser
Will Fulgent Genetics Inc. (7F0) stock outperform value peersWall Street Watch & Long-Term Investment Growth Plans - Newser
Fulgent Genetics Executives Sell Shares for Tax Obligations - TradingView — Track All Markets
What macro factors could drive Fulgent Genetics Inc. (7F0) stock higherAnalyst Downgrade & Daily Volume Surge Signals - Newser
Creative Planning Has $796,000 Stake in Fulgent Genetics, Inc. $FLGT - Defense World
Will Fulgent Genetics Inc. (7F0) stock boost dividends furtherEarnings Overview Report & Consistent Return Strategy Ideas - Newser
Fulgent Genetics (NASDAQ:FLGT) Insider Hanlin Gao Sells 943 Shares - MarketBeat
Fulgent Genetics: From Genetic Code To Cancer CureWhy I Assign A Hold Rating (NASDAQ:FLGT) - Seeking Alpha
Can Fulgent Genetics Inc. (7F0) stock surprise with quarterly resultsMarket Trend Summary & Verified Entry Point Detection - Newser
Finanzdaten der Fulgent Genetics Inc-Aktie (FLGT)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.56%
2.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):